Antibody–Drug Conjugates for Cancer Therapy

By Parslow Adam C.   Parakh Sagun   Lee Fook-Thean   Gan Hui K.   Scott Andrew M.  

Biomedicines, Vol. 4, Iss. 3, 2016-07 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy

By Mehrling Thomas   Soltis Daniel  

Antibodies, Vol. 7, Iss. 1, 2018-02 ,pp. : 11-11

MDPI

Access to resources Recommend Favorite

Factors Affecting the Pharmacology of Antibody–Drug Conjugates

By Lucas Andrew T.   Price Lauren S. L.   Schorzman Allison N.   Storrie Mallory   Piscitelli Joseph A.   Razo Juan   Zamboni William C.  

Antibodies, Vol. 7, Iss. 1, 2018-02 ,pp. : 10-10

MDPI

Access to resources Recommend Favorite

Methods to Design and Synthesize Antibody-Drug Conjugates (ADCs)

By Yao Houzong   Jiang Feng   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 194-194

MDPI

Access to resources Recommend Favorite

Linkers Having a Crucial Role in Antibody–Drug Conjugates

By Lu Jun   Jiang Feng   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 561-561

MDPI

Access to resources Recommend Favorite